阿联酋发行了两种新的生物皮肤药物,保险范围包括这两种药物,并迅速得到全球批准。 UAE launches two new biologic skin drugs, covered by insurance, with rapid global approval.

阿联酋在迅速获得国际批准后,针对稀有皮肤病推出了两种新药物。 The UAE has launched two new medications for rare skin conditions, following rapid international approval. 一种是每14天注射一次生物注射,另一种是60岁以上成年人的恶性皮肤炎,每两周进行生物治疗。 One treats hidradenitis suppurativa with a biologic injection every 14 days, and the other targets bullous dermatoses in adults over 60 with a biologic therapy every two weeks. 两者均由保险承保。 Both are covered by insurance. 在迪拜举行的第九届阿联酋皮肤病学会议强调了AI在皮肤诊断、激光技术和美学医学方面的进展,强调改善病人护理以及阿联酋作为快速跟踪全球治疗的区域枢纽的作用。 The 9th Emirates Dermatology Conference in Dubai highlighted advancements in AI for skin diagnosis, laser technology, and aesthetic medicine, emphasizing improved patient care and the UAE’s role as a regional hub for fast-tracking global treatments.